Aeromics Inc.

Aeromics is developing new small molecule therapeutics, exploiting a novel target for the treatment of CNS edema. The company will exploit the founders’ expertise in the biological control of water and gas permeation in pathological and normal tissues.

Funding: Grants, Broadview Ventures, Connecticut Innovations, Minerva Bridge, Angels and Archangels